- Home
- FRGE vs RNAC Comparison
FRGE vs RNAC Comparison
Compare FRGE & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- RNAC
- Stock Information
- Founded
- FRGE 2014
- RNAC 2007
- Country
- FRGE United States
- RNAC United States
- Employees
- FRGE N/A
- RNAC N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- RNAC Health Care
- Exchange
- FRGE Nasdaq
- RNAC Nasdaq
- Market Cap
- FRGE 262.8M
- RNAC 276.3M
- IPO Year
- FRGE N/A
- RNAC 2016
- Fundamental
- Price
- FRGE $18.30
- RNAC $9.99
- Analyst Decision
- FRGE Buy
- RNAC Strong Buy
- Analyst Count
- FRGE 5
- RNAC 4
- Target Price
- FRGE $35.50
- RNAC $40.00
- AVG Volume (30 Days)
- FRGE 89.3K
- RNAC 52.1K
- Earning Date
- FRGE 11-05-2025
- RNAC 11-06-2025
- Dividend Yield
- FRGE N/A
- RNAC N/A
- EPS Growth
- FRGE N/A
- RNAC N/A
- EPS
- FRGE N/A
- RNAC N/A
- Revenue
- FRGE $90,840,000.00
- RNAC $1,026,000.00
- Revenue This Year
- FRGE $32.56
- RNAC N/A
- Revenue Next Year
- FRGE $21.75
- RNAC N/A
- P/E Ratio
- FRGE N/A
- RNAC N/A
- Revenue Growth
- FRGE 14.78
- RNAC N/A
- 52 Week Low
- FRGE $6.60
- RNAC $8.46
- 52 Week High
- FRGE $24.90
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- FRGE 50.57
- RNAC 44.66
- Support Level
- FRGE $15.58
- RNAC $9.12
- Resistance Level
- FRGE $17.93
- RNAC $10.08
- Average True Range (ATR)
- FRGE 1.07
- RNAC 0.57
- MACD
- FRGE -0.09
- RNAC -0.01
- Stochastic Oscillator
- FRGE 74.16
- RNAC 47.95
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.